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Differential Tolerance Is Induced
in T Cells Recognizing Distinct Epitopes
of Myelin Basic Protein
processed MBP. In addition to these epitopes, MBP61-
80, MBP101-120, MBP121-140, and MBP131-150 have
been described as cryptic epitopes (Bhardwaj et al.,
1994). T cell responses were elicited to these epitopes
by immunization with synthetic peptides; however, these
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stages of EAE (Lehmann et al., 1992), presumably re-
flecting the phenomenonof determinant spreading (Leh-
mann et al., 1993; Miller et al., 1995).Summary
The ability to induce EAE indicates that induction of
tolerance to CNS antigens is incomplete. The tightnessExperimental allergic encephalomyelitis (EAE) is in-
of the blood±brain barrier surrounding the CNS, lack ofduced by T cell±mediated immunity to central nervous
lymphatic drainage, and prolonged survival of allo-system antigens. In H-2u mice, EAE is mediated primar-
graphs within this tissue support the idea that the CNSily by T cells specific for residues 1±11 of myelin basic
is an immunologically privileged site (Barker and Bill-protein (MBP). We demonstrate that differential toler-
ingham, 1977; Williams and Hickey, 1995; Weller et al.,ance to MBP1-11 versus epitopes in MBP121-150 is
1996). These observations indicated that tolerance toinduced by expression of endogenous MBP, reflecting
CNS antigens may not occur because these antigensextreme differences in stability of peptide/MHC com-
are sequestered from normal lymphocyte trafficking.Re-plexes. The diverse MBP121-150±specific TCR reper-
cent data suggest, however, that expression of MBPtoire can be divided into three fine specificity groups.
may not be limited to the CNS. Transcripts encodingTwo groups were identified in wild-type mice despite
MBP have been detected in the thymus (Mathisen et al.,extensive tolerance, but the third group was not de-
1993; Pribyl et al., 1993), and evidence for expressiontected. Activated MBP121-150±specific T cells induce
of MBP protein in the thymus has recently been reportedEAE in wild-type mice. Thus, encephalitogenic T cells
(Fritz and Zhao, 1996). Therefore, the expression of MBPthat escape tolerance either recognize short-lived
outside the CNS may induce T cell tolerance, and MBP-peptide/MHC complexes or express TCRs with unique
specific T cells found in theperiphery may have escapedspecificities for stable complexes.
mechanisms of tolerance induction.
To test this hypothesis, we compared the immune
Introduction response toMBP in wild-type animals and shiverer mice,
which have a deletion in the last five exons of the MBP
Experimental allergic encephalomyelitis (EAE) is in- gene (Dupouey et al., 1979; Kirschner and Ganser, 1980;
duced either by immunization with central nervous sys- Roach et al., 1985). Although the first two exons of the
tem (CNS) antigens in complete Freund's adjuvant (CFA) MBP gene are present in this mutant strain, the tran-
or by adoptive transfer of activated CNS-specific T cells scripts are very unstable and truncated protein cannot
into naive recipients (Paterson, 1976; Zamvil et al., 1985). be detected (Readhead and Hood, 1990). Therefore, shiv-
Transfer of CD41 T helper type 1 (Th1) T cells specific erer mice are considered to be MBP-deficient (MBP2/2),
for CNS antigens into naive recipients is sufficient to with the caveat that a very low level of protein corre-
induce EAE, suggesting that the primary mediators of sponding to the first two exons of MBP may still be
the disease are contained within this T cell subset. expressed. Earlier studies supported the idea that T cell
The major autoantigen targeted in EAE in H-2u mice responses to MBP in MBP2/2 mice may differ from those
is myelin basic protein (MBP). A single immunodominant observed in wild-type (MBP1/1) mice (Zaller and Sloan,
epitope contained within amino acids 1±20 of MBP has 1996). Immunization of MBP2/2 mice with MBP stimu-
been defined (Fritz et al., 1983, 1985; Zamvil et al., 1986). lated T cell responses to both MBP121-140 and MBP1-
Additional studies using smaller synthetic peptides have 11 instead of to MBP1-11 alone.
shown that the epitope is contained within MBP1-11 and We show here that two epitopes contained within
is associated with I-Au major histocompatibility (MHC) MBP121-150 are generated by processing whole MBP.
molecules. MBP1-11±specific T cells express a limited In MBP2/2 mice, epitopes within MBP121-150 represent
set of T cell receptors (TCRs) predominantly using Vb8.2 the immunodominant epitopes and MBP1-11 is a sub-
paired with either Va2.3 or Va4.2 (Acha Orbea et al., dominant epitope. In wild-type mice, however, the ma-
1988; Urban et al., 1988). A minor, subdominant epitope jority of T cells recognizing epitopes within MBP121-150
that associates with I-Eu MHC molecules has also been undergo a high degree of tolerance, while MBP1-11±
identified within MBP35-47 (Zamvil et al., 1988). T cells specific T cells escape tolerance induction. This differ-
specific for either of these epitopes recognize MHC ential tolerance correlates with extreme differences in
complexes formed from synthetic peptides as well as the stability of peptide/MHC complexes formed from
MBP121-150 versus MBP1-11. We also show that T cells
responding to epitopes within MBP121-150 can be di-§To whom correspondence should be addressed (e-mail: goverman
@u.washington.edu). vided into three different groups defined by fine antigen
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specificity. A few of these MBP121-150±specific T cells
are found in wild-type mice; however, the relative per-
centage of each fine specificity group differs between
MBP1/1 and MBP2/2 mice. Thus, differences in TCR
affinities between the specificity groups may influence
tolerance induction among MBP121-150±specific T
cells. Both MBP1-11± and MBP121-150±specific T cells
induce EAE upon adoptive transfer into naive recipients.
Results
The Predominant Response to MBP in MBP2/2 Mice
Is Directed toward Epitopes within MBP121-140
and MBP131-150 Rather Than MBP1-20
To compare T cell responses to MBP in H-2u MBP1/1
and MBP2/2 mice, the shiverer mutation was back-
crossed onto the B10.PL background for nine genera-
tions. MBP2/2 and MBP1/1 mice were immunized with
whole MBP in CFA. Cells were isolated from draining
lymph nodes after 10 days and purified T cells were
stimulated in vitro with irradiated, syngeneic antigen-
presenting cells (APCs) and a panel of overlapping 20-
mer peptides spanning the length of the MBP protein.
Because the yield of cells was lower from MBP1/1 immu-
nized mice than from MBP2/2 immunized mice, MBP1/1
lymph node cells from several mice were pooled before
T cell purification. The proliferative response of T cells
isolated from MBP1/1 mice was lower than the response
of T cells isolated from MBP2/2 mice to both MBP and
the MBP peptides. The data in Figure 1A demonstrate
that MBP1-20 contains the immunodominant epitope Figure 1. Proliferative Response of T Cells Isolated from MBP-
on the MBP1/1 background, as observed in previous Primed Mice to Overlapping Peptides Constituting MBP as Well as
studies (Zamvil et al., 1986, 1987; Fritz and McFarlin, MBP Protein
1989). (A) Response of T cells isolated from MBP1/1 mice. Cells isolated
from draining lymph nodes were pooled from one group of threeT cell responses to the other peptides in the panel
immunized MBP1/1 mice (filled bars) and another group of two im-were all very similar, indicating that no subdominant
munized MBP1/1 mice (open bars). T cells were purified twice overresponses to other epitopes were detected in these
nylon wool columns. Purified T cells were incubated with syngeneic
experiments. In contrast to MBP1/1 mice, strong re- irradiated APCs and 30 mM peptide as indicated or 3 mM MBP.
sponses are observed by stimulating T cells from immu- Proliferation was measured as the incorporation of [3H]thymidine
nized MBP2/2 mice to two peptides, MBP121-140 and and the stimulation index calculated. Data are representative of five
experiments using pooled lymph node cells as well as experimentsMBP131-150, as well as whole MBP (Figure 1B). Al-
in which proliferation of bulk lymph node cells to the panel of pep-though a subdominant response to MBP35-47 has pre-
tides was measured from 13 individual wild-type mice.viously been observed in T cells derived from PLJ/SJL
(B) Response of T cells from MBP2/2 mice. T cells purified from twoF1 mice (Zamvil et al., 1988; Sakai et al., 1989), a signifi-
MBP2/2 mice were stimulated as described in (A). Similar data were
cant response to MBP31-50 was not observed on either obtained by measuring proliferation of lymph nodes cells from 24
the MBP1/1 or MBP2/2 background in theseexperiments individual MBP2/2 mice.
or in earlier work (Zaller and Sloan, 1996). Differences
in these results may reflect differences between PLJ/
SJL and B10.PL mice. Alternatively, the MBP31-50 pep- stimulation assay, indicating that the T cells in wild-type
mice did not exhibit anergy that could be reversed intide may not efficiently stimulate T cells that respond
to MBP35-47. Our results demonstrate that, in the ab- vitro (data not shown).
sence of immune tolerance, epitopes contained within
MBP121-150 are immunodominant and MBP1-20 is a MBP121-140±Specific T Cells Induce
EAE in MBP1/1 Micesubdominant epitope.
The possibility that the lack of response to MBP121- MBP1-11±specific T cells obtained from mice primed
with MBP secrete Th1 cytokines upon restimulation in140 and MBP131-150 was due to induction of anergy
in wild-type mice was investigated. The proliferative re- vitro and induce EAE upon adoptive transfer into naive
recipients (Zamvil and Steinman, 1990). To determinesponses of lymph node cells from MBP1/1 mice primed
with MBP to stimulation with MBP1-11, MBP121-140, whether MBP121-140±specific T cells also exhibit a Th1
phenotype, MBP2/2 mice were immunized with MBP,and MBP131-150 peptides were compared in the pres-
ence and absence of interleukin-2 (IL-2). Responses to and cells from draining lymph nodes were stimulated in
vitro with either MBP1-11 or MBP121-140. Analyses ofthese peptides were not altered by including IL-2 in the
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cytokines in supernatants from these cultures demon-
strated that MBP1-11±stimulated cultures contained 300
pg/ml of interferon-g (IFNg) and no detectable IL-4. Su-
pernatants from MBP121-140±stimulated cells contained
7.2 ng/ml IFNg/ml and 50 pg/ml IL-4. Thus, T cells spe-
cific for both epitopes produce predominantly Th1 cyto-
kines. MBP121-140 stimulated much higher levels of
proliferation than stimulation with MBP1-11 in lymph
node cells from MBP2/2-primed mice, accounting for the
increased concentration of cytokines in these cultures.
To determine whether MBP121-140±specific T cells
were encephalitogenic, MBP2/2 mice were immunized
with MBP and lymph node cells, and splenocytes were
restimulated in vitro with MBP121-140. Activated T cells
were transferred into four naive MBP1/1 mice and one
Rag2/2 MBP1/1 mouse. EAE developed in the Rag2/2
recipient as well as in two of the four wild-type recipi-
Figure 2. The MBP121-140 Peptide Forms a Very Stable Complex
ents. Pathological examination revealed CNS lesions with I-Au MHC Molecules
consistent with EAE (data not shown). Thus, MBP121- Representative data for the dissociation of fluorescein-labeled
140±specific T cells can recognize an MBP epitope that MBP121-140 and MBP1-11 peptides from affinity-purified I-Au. The
is naturally processed in the CNS and can then initiate amount of peptide bound was determined by HPSECusing a fluores-
cence detector and has been normalized to the amount initiallyEAE.
bound. The lines are fits of single exponential functions to the data.
The t1¤2 values were determined from the exponential fits to three
independently measured dissociation curves.MBP121-140 Forms Very Stable Complexes with
Soluble I-Au MHC in Contrast to the Unstable
Complexes Formed with MBP1-11
complex, dissociating from I-Au with a t1¤2 of 144 hr (Fig-To investigate the mechanism for differential tolerance
ure 2). Thus, the difference in the ability of these twoinduction in MBP-specific T cells, we performed kinetic
peptides to induce T cell tolerance is correlated with aanalyses of the binding of MBP1-11 and MBP121-140
difference in the stability of complexes formedwith MHCto soluble I-Au MHC molecules. Previous studies have
molecules.shown that the MBP1-11 peptide binds very weakly to
I-Au molecules (Fairchild et al., 1993; Mason et al., 1995).
Similar TCR Va and Vb Gene Usage Is Observed onThe peptide/MHC complexes dissociate rapidly, with a
MBP1-11±Specific T Cell Hybridomas Isolatedhalf-life (t1¤2) of about 15 min. It was suggested that this
from MBP2/2 and MBP1/1 Micerapid dissociation limited the availability of the epitope
Because T cell responses to MBP1-11 are detected inin vivo for interaction with T cells, accounting for the
MBP1/1 mice as well as MBP2/2 mice, it was not clearability of MBP1-11±specific T cells to escape tolerance
whether any of these cells undergo tolerance induction.induction. We reasoned that if the low affinity of the
If some tolerance is induced by this epitope, differencesMBP1-11 epitope was responsible for escape from toler-
in the TCR repertoire of MBP1-11±specific T cells mayance induction, the observed tolerance to the MBP121-
be apparent in MBP2/2 versus MBP1/1 mice. MBP1-140 epitope might be due to a higher affinity of this
11±specific T cell hybridomas from B10.PL MBP1/1 micepeptide for I-Au molecules. Therefore we studied the
express predominantly Vb8.2 and Va2.3 (Urban et al.,binding of the two peptides, MBP1-11 and MBP121-
1988). To determine whether a more diverse TCR reper-140, to purified I-Au molecules to assess the dissociation
toire is observed on MBP1-11±specific T cells in thekinetics.
absence of tolerance induction, MBP2/2 mice were im-The binding of fluorescein-labeled MBP peptides to
munized with MBP and hybridomas were generatedaffinity-purified I-Au molecules was determined by mea-
from T cells stimulated in vitro with MBP1-11. The TCRsuring the amount of fluorescence associated with pro-
repertoire of 14 hybridomas was characterized by flowtein using high-performance size-exclusion chromatog-
cytometry using antibodies specific for Va2 and a panelraphy (HPSEC) and a fluorescence detector (Mason et
of Vb genes. A limited TCR repertoire was also observedal., 1995). After 24 hr of incubation with peptide, the
in these hybridomas, with 93% expressing Va2 V genesamount of MBP121-140 peptide bound to I-Au was about
and 79% expressing Vb8.1/8.2 V genes. Vb3 was ex-20-fold higher than the N-terminal acetylated MBP1-11
pressed on 7% of the hybridomas. Thus, expression ofpeptide (data not shown). A more reliable indicator of
MBP does not appear to alter significantly the repertoirerelative affinities is a comparison of the dissociation
of TCRs expressed on MBP1-11±specific T cells.rates for the two peptide/MHC complexes.The dissocia-
tion of the bound peptide was monitored by loss of
fluorescence associated with the peptide/MHC complex Differential Tolerance Is Induced by Distinct
Epitopes within MBP121-150as measured by HPSEC. As reported previously (Mason
et al., 1995), the N-terminal acetylated MBP1-11 peptide The response to MBP121-140 in vitro by T cells isolated
from mice immunized with whole MBP is dramaticallydissociated from I-Au with a t1¤2 of 15 min (Figure 2). In
contrast, the MBP121-140 peptide formed a very stable reduced in MBP1/1 mice compared to MBP2/2 mice.
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Nevertheless, some T cells specific for MBP121-140 are
primed in MBP1/1 mice by immunization with whole
MBP. Presumably, these MBP121-140 responsive T
cells in MBP1/1 mice represent cells that have escaped
induction of tolerance.
Some MBP121-140±specific T cells in MBP1/1 mice
could randomly escape induction of tolerance if the
mechanisms of tolerance induction are not 100% effi-
cient. In this case, the number of T cells specific for
MBP121-140 epitopes will be reduced in MBP1/1 mice
compared to MBP2/2 mice, but the T cells isolated from
the two backgrounds should not differ significantly in
terms of their antigen fine specificity or TCR repertoire.
Alternatively, T cells responding to the MBP121-140 re-
gion may be a heterogeneous population in which dis-
tinct subsets of T cells undergo tolerance induction to
different degrees. Differential tolerance could arise if
MBP121-150±specific TCRs differ in their affinity for the
peptide/MHC complexes that they recognize. Within this
region, differential tolerance could also occur if there is
formation of multiple peptide/MHC complexes whose
abundance on the cell surface of APCs varies because
of differences in the efficiency of processing or in the
affinity of the processed peptides for MHC molecules.
T cells specific for epitopes that are present at a lower
concentration on the cell surface may escape tolerance
more easily. If the MBP121-140±specific T cells do un-
dergo differential tolerance, the cells remaining in MBP1/1
mice should be distinguished from the MBP121-140±
specific T cells found in MBP2/2 mice either by differ-
ences in fine antigen specificity (indicative of recogniz-
ing distinct epitopes) or differences in TCR repertoire.
To investigate whether differential tolerance is ob-
served among MBP121-140±specific T cells, we gener-
ated T cell hybridomas from both MBP1/1 mice and
MBP2/2 mice. Hybridomas were generated by immuniz-
ing with MBP protein and stimulating lymphocytes in
vitro with MBP121-140 prior to fusion. Two separate
fusions from cells isolated from seven MBP2/2 mice
produced 24 distinct T cell hybridomas. Because of Figure 3. Fine Antigen Specificity of T Cells Responding to Epitopes
lower abundance of MBP121-140±specific T cells in within the MBP121-150 Region of MBP
MBP1/1 mice, 14 T cell hybridomas were obtained using (A) Peptides used to define fine antigen specificity of T cell hybrido-
33 MBP1/1 mice in five different fusions. Fine specificity mas. T cells can be divided into three groups based on patterns of
responsiveness to the overlapping peptides. Diamonds representof the hybridomas was analyzed by measuring IL-2 pro-
the peptides to which T cells in each group respond; lines indicateduction of cells stimulated in vitro with six peptides
peptides to which there is no response.overlapping the MBP121-150 region. The peptides in-
(B) Response of individual T cell hybridomas representative of eachcluded MBP111-130, 121-140, 126-140, 131-150, 131-
of the three fine antigen specificity groups. This graph shows the
140, and 141-160. No responses were detected to response of the hybridomas to the peptides used to distinguish
MBP111-130, 131-140, and 141-160 (binding studies us- these groups as well as the reponse to MBP. IL-2 production by
ing MBP131-140 showed that this peptide does not bind the hybridomas in response to antigen stimulation was measured
by proliferation of HT-2 indicator cells.to the I-Au MHC molecules). Responses to the remaining
peptides divided the hybridomas into three distinct
groups, which are defined in Figure 3A. Group 1 re-
cell stimulation. Two unique core epitopes, MBP125-sponded only to MBP121-140; group 2 responded to
135 and MBP136-146, were identified (C. Loftus and C.both MBP121-140 and 126-140; and group 3 responded
Beeson, unpublished data). Both of these core peptidesto MBP121-140, 126-140, and 131-150. All of these hy-
formed very stable complexes with MHC molecules,bridomas remained responsive to intact MBP. Typical
with dissociation t1¤2 values of 270 and 180 hr respec-responses of groups 1, 2, and 3 T cell hybridomas are
tively. Whereas all three specificity groups respondedshown in Figure 3B.
to the first core epitope, only group 3 T cells appearedThe lack of any stimulation and MHC binding by the
to respond to both the first and second core epitopes.overlapping peptide MBP131-140 suggested the pres-
Interestingly, the distribution of hybridomas amongence of two distinct epitopes in the MBP121-140 and
these fine specificity groups was different in the panelMBP131-150 peptides. These peptides were progres-
sively truncated and assayed for MHC binding and T of hybridomas isolated from MBP2/2 and MBP1/1 mice
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Table 3. Va and Vb Usage in Group 2 Hybridomas from MBP1/1Table 1. Distribution of Hybridomas Derived from the MBP2/2
and MBP1/1 Mice among the Fine Specificity Groups and MBP2/2 Mice
Group 1 Group 2 Group 3 MBP2/2 MBP1/1 MBP2/2 MBP1/1
MBP2/2 4% (1/24) 50% (12/24) 46% (11/24) Va2 1 1 Vb2 1 3
Va3 1 Vb3 1MBP1/1 43% (6/14) 57% (8/14) 0% (0/14)
Va5 1 1 Vb4 3
Hybridomas were graded as responding or not responding in com- Va8 1 2 Vb8 6 2
parison to the controls. Table shows the percentage of hybridomas Va11 1 Vb10 1
from either the MBP1/1 mice or the MBP2/2 mice that fall into the Va15 1 Vb16 1
given groups. Va16 2
Va19 3
n 5 9 n 5 6 n 5 12 n 5 6
TCR Va and Vb chain usage in group 2 hybridomas in MBP1/1(Table 1). In MBP2/2 mice, only one hybridoma (4% of
and MBP2/2 mice is displayed. Data were obtained from surfacethe total) exhibited group 1 specificity, while 50% of
antibody staining and sequence analysis.the hybridomas represented group 2 and 46% repre-
sented group 3. Because these T cells were derived
in the absence of induction of tolerance to MBP, this
Vb8 and Vb4 gene segments were utilized more fre-distribution may reflect the relative precursor frequency
quently than other Vb gene segments (Table 2). Expres-of T cells exhibiting these fine specificities. This distribu-
sion of these Vb genes does not correlate with a particu-tion differed significantly from the distribution observed
lar specificity group, however, since they representedamong the hybridomas derived from MBP1/1 mice (p 5
65%±80% of the Vb genes in all groups. The Vb8 genes0.000973). Of the MBP1/1 hybridomas, 43% represented
expressed on these TCRs were associated with sevengroup 1 and 57% represented group 2. No MBP1/1 hy-
different Jb gene segments, and the Vb4 genes werebridomas exhibited group 3 specificity.
associated with six different Jb gene segments (data
not shown). This is very different from the reported TCRsThe TCR Repertoire of MBP121-150±Specific
specific for MBP1-11 in B10.PL mice, in which the pre-Hybridomas Is Very Diverse and Does Not
dominant Vb8.2 gene was associated only with Jb2.6Correlate with Antigen Fine Specificity
and the Va2.3 gene was associated only with Ja39 (Ur-The TCR repertoires expressed on the MBP1/1 and
ban et al., 1988).MBP2/2 hybridomas were analyzed to determine whether
The Va gene usage was also extremely diverse (Tableparticular TCR V genes were associated with different
2). Of 16 Va genes analyzed in group 2 hybridomas,fine specificity groups. TCR expression was character-
eight expressed Va genes from different subfamilies.ized by staining with Va- and Vb-specific antibodies and
Seven of 11 Va genes analyzed from group 3 hybridomasin most cases by TCR V gene sequencing. The V gene
expressed different Va genes, although Va2 was ex-usage for the hybridomas is displayed according to fine
pressed on 4 of these hybridomas. Too few sequencesspecificity group in Table 2. All specificity groups exhib-
were obtained from group 1 hybridomas to establishited diversity in the repertoire of both Va and Vb genes.
the degree of diversity in these cells. Given the high
degree of diversity in TCRs expressed in each group,
we could not define patterns of V gene usage that distin-Table 2. TCR a- and b-Chain Diversity within the Fine Specificity
Groups guished one group from another. The diversity exhibited
in the TCR repertoire in all three specificity groups differsGroup 1 Group 2 Group 3
from therelatively limited expression of Va and Vb genes
Va2 2 2 4 observed for MBP1-11±specific T cells in MBP1/1 and
Va3 1 1
MBP2/2 mice.Va5 2 1
T cells with group 2 specificity represented the sameVa8 3 1
percentage in the panels of hybridomas derived fromVa11 1 1
Va13 1 MBP1/1 and MBP2/2 mice (Table 1). Nevertheless, some
Va14 2 group 2 T cells may undergo tolerance in MBP1/1 mice,
Va15 1 because the overall response to MBP was diminished
Va16 2
in MBP1/1 mice relative to MBP2/2 mice. The Va and VbVa19 4 1
gene usage was compared for group 2 hybridomas from
Vb1 1 MBP1/1 and MBP2/2 mice to determine whether the
Vb2 4 1
possible induction of tolerance altered the repertoire ofVb3 1
TCRs expressed on cells with this specificity in the twoVb4 4 3 3
backgrounds. The Va and Vb genes expressed on groupVb8 2 8 5
Vb10 1 2 hybridomas from MBP1/1 and MBP2/2 mice were very
Vb15 1 diverse (Table 3). Some differences may exist between
Vb16 1 MBP1/1 and MBP2/2 group 2 T cells, since Vb2 was
TCR a- and b-chain diversity in MBP121-140±specific T cells. TCR expressed on 3 of 6 MBP1/1 hybridomas but on only 1
V region usage was assessed by surface antibody staining and TCR of 12 MBP2/2 hybridomas. Va19 was found in 3 of 9
sequencing. The number of T cell hybridomas using the given V hybridomas from MBP2/2 mice but was not expressed
region in the respective fine specificity groups is displayed.
on any of the 6 MBP1/1 hybridomas. The gene segments
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specific T cells induce disease upon adoptive transfer,Table 4. Va/Vb Gene Pair Usage in MBP2/2 versus MBP1/1
indicating that they can recognize MBP epitopes derivedHybridomas from All Fine Specificity Groups
from whole MBP processed in the CNS. Thus, the low
MBP2/2 MBP1/1
response to MBP121-140 in MBP1/1 mice following im-
Vb8/Va2 2 1 munization with whole protein lies at the level of T cell
Vb8/Va5 1 tolerance rather than antigen processing.
Vb8/Va8 2 Kinetic analyses of the binding of MBP121-140 and
Vb8/Va11 1
MBP1-11 to soluble I-Au MHC molecules establish aVb8/Va13 1
basis for the differential induction of tolerance to theseVb8/Va14 1 0
two MBP epitopes. Previous studies demonstrated thatVb8/Va16 1
Vb8/ND 1 MBP1-11 forms a complex with I-Au that has a short t1¤2
(Fairchild et al., 1993; Mason et al., 1995). The instabilityVb4/Va2 1 1
of these complexes should decrease their abundanceVb4/Va5 1
Vb4/Va14 1 on the cell surface and consequently the frequency with
Vb4/Va19 1 which they interact with T cells. In supportof the hypoth-
Vb4/ND 3 2 esis that interactions in vivo between MBP1-11/MHC
complexes and T cells do not contribute significantly toVb2/Va8 1
Vb2/Va5 1 tolerance induction, T cells expressing more diverse
Vb2/Va8 1 MBP1-11±specific TCRs that might have been elimi-
Vb2/Va19 2 nated in MBP1/1 mice are not found in MBP2/2 mice.
Only Vb8, Vb4, and Vb2 were represented more than once in our In contrast to the unstable MBP1-11/MHC complex,
combined MBP1/1 and MBP2/2 hybridoma panels. Values indicate we demonstrate that epitopes within MBP121-150 form
the number of times a particular pair was observed. highly stable complexes with I-Au. Previous studies have
shown that more stable peptide/MHC complexes persist
longer on the APC surface (Nelson et al., 1994) and are
therefore more available for T cell surveillance (Rothbardpaired with Vb2 and Va19 genes were very diverse, how-
and Gefter, 1991). The concentration of a peptide/MHCever, suggesting that correlations with their usage in
ligand on the surface of APCs as well as the concentra-MBP1/1 versus MBP2/2 mice may not be significant.
tion and affinity of a TCR on T cells are important param-Table 4 summarizes all of the VaVb gene pairs for Vb
eters in triggering T cell activation (Kim et al., 1996).genes that were found more than once on MBP1/1 and
Other studies indicate that these factors also contributeMBP2/2 hybridomas specific for epitopes in MBP121-
to induction of T cell tolerance. More extensive T cell150. These data indicate that there is no predominant
deletion has been observed as a function of increasingVaVb pair expressed on either background.
affinity of peptide for MHC molecules and increasing
density (concentration) of peptide (Cabaniols et al.,Discussion
1994; Liu et al., 1995). Therefore, the increased stability
of the MBP121-140/MHC complex is consistent with
Our studies demonstrate that T cells that have matured
tolerance induction in MBP121-140±specific T cells due
in theabsence of endogenous MBP expression generate
to high-avidity interactions between epitope-specific T
a response to MBP that is predominately directed to- cells and APCs that process MBP in vivo.
ward two core epitopes contained in the MBP121-150 The epitope-specific induction of tolerance to MBP
region. T cells from MBP2/2 mice primed with intact MBP is in accord with earlier models that predicted tolerance
respond vigorously in vitro to the synthetic peptides to self-proteins would be incomplete and limited to im-
MBP121-140 and MBP131-150. The response to MBP1- munodominant determinants (Gammon and Sercarz,
20 in MBP2/2 mice, however, was only slightly higher 1989). Thus, the immune response to MBP is similar to
than responses to other peptides and was significantly other experimental systems that demonstrate induction
less than the responses to MBP121-140 and MBP131- of tolerance to immunodominant determinants of self-
150. Thus, MBP1-20 represents a subdominant epitope proteins while responses to subdominant determinants
in the absence of T cell tolerance induced by endoge- persist (Cibotti et al., 1992; Gu'ery et al., 1995).
nous synthesis of MBP. Results of our kinetic analyses define one mechanism
MBP121-140 has previously been characterized as a by which auto-reactive T cells specific for subdominant
cryptic epitope of MBP because T cells isolated from epitopes may escape tolerance. Our results do not im-
mice immunized with whole protein did not respond ply, however, that all autoreactive T cells that escape
significantly to this peptide in vitro and T cells isolated tolerance are specific for unstable peptide/MHC com-
from mice immunized with the MBP121-140 peptide did plexes. For example, the few MBP121-150±specific T
not respond to whole MBP in vitro (Bhardwaj et al., cells that remain in the periphery of MBP1/1 mice recog-
1994). Attention has recently focused, however, on the nize very stable complexes. In addition, the immuno-
importance of investigating both peripheral T cell toler- dominant epitope of proteolipid protein (PLP) in SJL
ance and antigen processing in defining ªcrypticº epi- mice (PLP139-151) appears to bind to I-As molecules
topes (Viner et al., 1995, 1996). We present two lines of with high affinity and is very encephalitogenic (Greer et
evidence that demonstrate that MBP121-140 is not a al., 1996). The basis for the escape from tolerance by
cryptic epitope. First, the MBP121-140±specific hybrid- PLP-specific T cells has not yet been established. It is
omas described here respond to both whole MBP and possible that PLP may not be expressed in high abun-
dance in the thymus or that PLP-specific TCRs maythe MBP121-140 peptide in vitro. Second, MBP121-140±
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have a lower affinity than MBP121-140±specific T cells of group 2 T cells is present in MBP1/1 mice compared
to MBP2/2 mice.for their ligand.
Despite the significant reduction in T cell responses We have shown that the restricted repertoire ex-
pressed on MBP1-11±specific T cells is not due to spe-to MBP121-140 in MBP1/1 mice, some T cells were still
present in wild-type mice that responded to this peptide cific deletion of T cells expressing other V genes be-
cause the V gene usage is very similar in MBP1/1 andafter immunization with whole MBP. We hypothesized
that MBP121-140±reactive T cells may be heterogeneous MBP2/2 mice. It is more likely that the TCR repertoire
is limited because only those T cells in the peripherywith respect to susceptibility to tolerance induction.
Comparison of the fine specificitiesof T cells responding with high-affinity receptors can be primed by peptides
that form short-lived peptide/MHC complexes. It is inter-to the MBP121-150 region found in MBP2/2 mice to
those present in MBP1/1 mice indicates that this is the esting that the immunodominant epitope of human MBP
in HLA-DR4 subjects, which is similar to the murinecase. T cells could be divided into three groups based
on fine antigen specificity using peptides overlapping MBP1-11 epitope in that it binds to the MHC molecule
weakly, elicits T cells expressing a very limited TCRthe MBP121-150 region. Hybridomas from the MBP2/2
mice were almost evenly divided between groups 2 and repertoire (Muraro et al., 1997).
Our analyses of the immune response to MBP indi-3; only one hybridoma fell into group 1. T cell hybridomas
from the MBP1/1 mice had a very different pattern of cates that the repertoire of encephalitogenic T cells in
B10.PL mice is determined by inductionof immune toler-responsiveness. Slightly more group 2 than group 1 hy-
bridomas were obtained, but no hybridomas exhibited ance mediated by endogenously expressed MBP and
consists primarily of T cells specific for short-lived MHCgroup 3 specificity. Thus, T cellsexhibiting group 3 spec-
ificity are effectively tolerized in MBP1/1 mice. complexes derived from MBP1±20. Activation of these
cells in vivo requires exposure to a high concentrationT cells exhibiting group 3 specificity are particularly
interesting in that they respond to both MBP121-140 of antigen in the periphery to achieve sufficient abun-
dance of the MHC complexes on APCs to trigger T cells.and MBP131-150.Precedents for recognition of multiple
unique epitopes by a single T cell have been demon- The repertoire also consists of some T cells specific for
long-lived MHC complexes derived from MBP121-150.strated in other studies (Nanda et al., 1995; Quaratino
et al., 1995; Tallquist et al., 1996). The structural basis Although these cells are encephalitogenic, they are not
the primary mediators of EAE, presumably because theyfor this apparent plasticity of the TCR in ligand recogni-
tion has been elucidated by recent crystallographic represent a very small component of the MBP-specific
peripheral repertoire. These cells could pose a greateranalyses (Garcia et al., 1998). The induction of tolerance
in group 3 T cells may result from interaction with either threat of autoimmune disease if a defect occurred in
the mechanism by which MBP induces tolerance in vivo.or both of the core epitopes in MBP121-150. Because
groups 1, 2, and 3 all recognize very stable MHC com- For example, if the level of expression of MBP epitopes
on cells that mediate tolerance decreased such thatplexes, the selective induction of tolerance in group 3
T cells is likely to arise from a higher affinity of their more T cells specific for MBP121-150 epitopes escaped
tolerance, a greater percentage of the repertoire wouldTCRs for MHC complexes relative to those expressed
on groups 1 and 2. consist of T cells that require a lower level of antigenic
exposure for activation. This possibility may have impli-Comparison of the percentages of groups 1, 2, and 3
T cell hybridomas derived from MBP1/1 and MBP2/2 cations for mechanisms underlying the development of
multiple sclerosis. Genes that influence mechanisms ofmice indicates that group 1 T cells are enriched in
MBP1/1 mice relative to MBP2/2 mice. Although no tolerance induction and/or environmental influences
that decrease the efficiency of induction of immune tol-group 3 hybridomas were derived from MBP1/1 mice,
the ratio of group 1 to group 2 hybridomas observed in erance (even temporarily) may change the repertoire of
self-reactive T cells to include a greater number of TMBP2/2 mice would be expected to remain the same in
MBP1/1 mice unless group 1 T cells were subjected to cells with the potential to be triggered by lower concen-
trations of self-antigen. Thus, both subdominant anddifferent selective pressures. The ratio of group 1 to
group 2 hybridomas is 1:12 in MBP2/2 mice, however, immunodominant epitopes may be potential targets in
the initiation of autoimmune disease.the ratio increases to3:4 inMBP1/1 mice (Table 1). Group
1 T cells may be enriched in MBP1/1 mice because they
escape tolerance induction more readily than group 2 Experimental Procedures
T cells. Alternatively, if group 1 T cells are positively
Miceselected instead of negatively selected by an MBP epi-
B10.PL(73NS)/Sn and heterozygote C3HeB/FeJ-Mbpshi/1 mice car-tope in MBP1/1 mice, they would exhibit low affinity
rying the shiverer mutation were obtained from the Jackson Labora-
for MBP peptide/MHC complexes in the periphery and tory (Bar Harbor, ME). The shiverer mutation was bred onto the
generate very weak, subdominant responses. In MBP2/2 B10.PL background, and offspring carrying the shiverer mutation
mice, this positive selection would not occur and fewer were identified using polymerase chain reaction (PCR) primers that
flank the deletion site in the MBP gene in shiverer mice. The primersgroup 1 T cells would be present in the periphery, re-
were 59-CAGGGGATGGGGATGCAGAAGTGAG-39 and 59-ATGTATGsulting in a decreased ratio of group 1 to group 2 T cells.
TGTGTGTGTGCTTATCTAGTGTA-39.The percentage of hybridomas with group 2 specificity
The shiverer mutation was bred onto the B10.PL background for
was similar in MBP1/1 and MBP2/2 mice. The high de- nine or more generations to generate experimental animals. Hetero-
gree of diversity in TCRs expressed on group 2 hybrido- zygote mice were bred together to generate homozygote MBP2/2
mas from both backgrounds and our limited sample size shiverer animals, which were identified by whole-body tremor.
MBP1/1 mice were littermate animals that were wild-type at bothlimit our ability to determine whether a distinct subset
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MBP loci. Mice were maintained inan specificpathogen±free facility, presence or absence of 30 mM peptide in a total volume of 200 ml.
Supernatant (50 ml/well) was transferred to another plate after 24and all procedures were approved by the Animal Care Committee
hr and frozen at 2808C. HT-2 responder cells (1 3 104 cells/well)at the University of Washington.
were added to the thawed supernatants, and proliferation was as-
sessed after 24 hr by adding [3H]thymidine for an additional 24 hrSynthetic Peptides
and harvesting the cultures.Peptides were synthesized using TBOC chemistry on a model 430A
Applied Biosystems Peptide Synthesizer in the Microchemical Facil-
FACS Stainingity at the California Institute of Technology or in the Biopolymer
T cell hybridomas were analyzed by flow cytometry analysis usingFacility at the University of Washington. Peptides were purified by
biotinylated antibodies (PharMingen, San Diego, CA) specific forreverse-phase HPLC. The MBP121-140 sequence is GFGYGGRAS
Va2, 3.2, 8, and 11 and Vb2, 3, 4, 5.1/5.2, 6, 7, 8.2/8.1, 8.3, 9, 10,DYKSAHKGFKG, and theMBP131-150 sequence is YKSAHKGFKGA
11, 12, and 14. Cells (1±2 3 106) were incubated with antibody for 30YDAQGTLSK.
min at room temperature, washed, and incubated with streptavidin-
conjugated Tricolor (Caltag Laboratories, San Francisco, CA) for 20Immunization of Mice
min to detect bound primary antibody. Cells were then washed,Five- to 10-week-old mice were anesthetized with xylazine (7 mg/
fixed, and analyzed on a FACScan (Becton-Dickinson, Mountainkg) and ketamine (100 mg/kg) diluted in saline and administered by
View, CA).intraperitoneal injection. Both hind foot pads were immunized with
mouse MBP (75 mg per mouse) in sterile phosphate-buffered saline
Sequence Analysis(PBS) emulsified in CFA containing 1 mg/ml mycobacterium tuber-
RNA was isolated from T cell hybridomas using RNA STAT-60 (Tel-culosis. MBP was purified from mouse brains (Pel-Freeze Biologi-
Test, Friendswood, TX) according to the manufacturer's instruc-
cals, Rogers, AR) using the method described by Norton and Po-
tions. cDNA was synthesized using a first-strand cDNA sequencing
duslo (1973). kit for AMV (avian myeloblastosis virus) reverse-transcriptase PCR
(Boehringer Mannheim, Indianapolis, IN) and amplified by PCR for
Lymph Node Stimulation Assay sequence analysis. PCR was carried out using either a Ca or Cb
Popliteal and inguinal lymph nodes were removed 10 days after primer and V gene primers designed to amplify known V gene sub-
immunization, and T cells were purified twice over nylon wool col- families. PCR products were precipitated and sequenced directly
umns. Lymphocytes from several immunized MBP1/1 mice were using the Taq Dye Deoxy Terminator Cycle Sequencing Kit (Applied
pooled prior to purification. T cells (7 3 105) were stimulated in Biosystems, Foster City, CA) on an Applied Biosystems 373A DNA
triplicate in 96-well round-bottom plates with irradiated syngeneic Sequencer. The PCR primers used were:
APCs in the presence of either individual peptides from the overlap- Ca: TTC AAG CTT AAG TCG GTG AAC AGG CAG AG
ping panel at a final concentration of 30 mM peptide, 3 mM MBP, Va1: GGG AAT TCT CC(G/C) TAC ACA TCA GAG ACT C
or media alone. Proliferation was assessed by adding 1 mCi of Va2: GGG AAT TCT CCT TGC ACA TTA CAG ACT C
[3H]thymidine after 48 hr of culture and harvesting after an additional Va4: GGG AAT TCC ATA TGA CAG AGG GAC CAC G
18 hr onto filter mats. The incorporated radioactivity was counted Va5: GGG AAT TCC GAA GGA CAA GGA TTC ACT G
on a b plate scintillation counter. Stimulation index was calculated Va6: GGG AAT TCA GTC AAG CAC CTC GAT CCT G
as the fold increase in counts per minute compared with counts Va7: GGG AAT TCT CCA TCA GCC TTG TCA TTT CA
incorporated in the absence of antigen. For assessment of anergy Va8: GGG AAT TCC GAG CAC CAA GGGG TTC TAC G
in peripheral T cells, stimulation of lymph node cells from MBP1/1 Va9: GGG AAT TCC AGC TCT TTG CAC ATT TCC TCC
mice was performed as described above except that triplicate sam- Va11: GGG AAT TCG CAC CCT GCA CAT CAG GGA TG
ples were analyzed using MBP1-11, MBP121-140, MBP131-150 and Va12: GGG AAT TCA GCA CTC TGA GCC TGC CCT GG
MBP in the presence or absence of 50 U recombinant IL-2. Va13: GGG AAT TCG CTT TGA GGC TGA GTT CAG C
Va14: GGG AAT TCG CAC GCT GCA CAT CAC AGC C
Va15: GGG AAT TCC GCA ATG GAA GAC TCA GAG CCytokine Analysis
Va16: GGG AAT TCT TCC ATC GGA CTC ATC ATC ACSerial dilutions of supernatants from 1 3 107 lymph node cells iso-
Va17: GGG AAT TCA GCC GCT CGA ATG GGT ACA Glated from MBP2/2 mice immunized with MBP and stimulated in
Va18: GGG AAT TCT CCT TAC ATA TAA CAG CTG CAvitro with either 20 mM MBP1-11 or 20 mM MBP121-140 in 24-
Va19: GGG AAT TCG ATT CTC CCT GCA CAT CAC AGwell plates were analyzed for the presence of IFNg and IL-4 using
Cb: TC AAG CTT CCA AGC ACA CGA GGG TAG CCQuantikine M kits (R&D Systems, Minneapolis, MN) according to
Vb1: GGG AAT TCC CTG AAT GCC CAG ACA GCT CCthe manufacturer's instructions.
Vb2: GGG AAT TCG GCC ACA CGG GTC ACT GAT ACG
Vb3: GGG AAT TCC GAT TCT CTG CTG AGT GTC CTT CDisease Induction
Vb4: GGG AAT TCC AGA CTG CCT CAA GTC GCT TCCFive- to 10-week-old MBP2/2 mice were immunized with 100 mg
Vb5: GGG AAT TCG GA(T/A) ( T/A)CC T(A/G)C CCA GCA GATMBP. Lymph node cells and splenocytes were isolated 10 days after
TCT Cimmunization and stimulated for 3 days with 20 mM MBP121-140
Vb6: GGG AAT TCG ATG CGT CTC GAG AGA AGA AGT Cat 1 3 107 cells/ml in 24-well plates. Cells (5 3 107) were injected
Vb7: GGG AAT TCT ACA GGG TCT CAC GGA AGA AGCin 150 ml of PBS into the tail vein of 5- to 10-week-old wild-type or
Vb8: GGG AAT TCG GAG AT(A/G) TCC CTG ATG G(A/G)T ACARag2/2 recipients. Pertussis toxin (400 ng in 100 ml of PBS) was
AGadministered intraperitoneally on days 0 and 2.
Vb9: GGG AAT TCG TTC CAA TCC AGT CGG CCT AAC
Vb10: GGG AAT TCC CAA GGC GCT TCT CAC CTC AGT C
Generation of T Cell Hybridomas Vb11: GGG AAT TCG CCC AAG GAA CGA TTC TCA GCT C
Mice were immunizedwith 75 mg of mouse MBP as described above. Vb12: GGG AAT TCG ATG GTG GGG CTT TCA AGG ATC
Draining lymph nodes were removed 10 days after immunization, Vb13: GGG AAT TCA GTT TAC TTT CGG GAT GAG GCT G
and single-cell suspensions of 1 3 107 cells/well were stimulated in Vb14: GGG AAT TCG CTT CCA GGC CGA AGG ACG ACC
24-well plates with 30±60 mM MBP121-140 peptide. The resulting Vb15: GGG AAT TCC CCA TCA GTC ATC CCA ACT TAT CC
T cell blasts were fused after 72 hr to BW5147a2b2 cells using Vb16: GGG AAT TCC AGA TTT TAG GAC AGC AGA TGG AG
standard procedures. Hybridomas were screened for respon- Vb18: GGG AAT TCC CAA TCA GCC GGC CAA ACC TAA C
siveness to MBP121-140 by detecting IL-2 production using HT-2 Vb19: GGG AAT TCG CCC TGC TAA GAA ACC ATG TAC C
responder cells. Hybridomas that reacted specifically to peptide Vb20: GGG AAT TCG GGT CAA GGA GAG ATT CTC AGC TG
were then cloned by limiting dilution.
Fluorescent Peptides and MHC Binding
IL-2 Stimulation Assay Peptides were synthesized with standard FMOC (fluorenylmethoxy-
IL-2 assays were performed in 96-well round bottom plates with carbonyl) chemistry on an Applied Biosystems 431A peptide synthe-
sizer and cleavedwith trifluoroacetic acid. The MBP121-140 peptide1 3 105 T cell hybridomas and 5 3 105 irradiated spleen cells in the
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was labeled at the N-terminus with the N-hydroxysuccinimidyl ester Baumann, N. (1979). Immunochemical studies of myelin basic pro-
tein inshiverer mouse devoid of major dense line of myelin. Neurosci.of 5(6)-carboxyfluorescein prior to cleavage. The N-terminal acet-
Lett. 12, 113±118.ylated MBP1-11peptide was synthesized with an additional C-termi-
nal cysteine that was labeled with 5(6)-carboxyfluorescein iodoacet- Fairchild, P.J., Wildgoose, R., Atherton, E., Webb, S., and Wraith,
amide after cleavage. All peptides were purified by reverse-phase D.C. (1993). An autoantigenic T cell epitope forms unstable com-
HPLC purification (acetonitrile/water gradient), and their identity was plexes with class II MHC: a novel route for escape from tolerance
confirmed by mass spectrometry. Synthesized peptides were active induction. Int. Immunol. 5, 1151±1158.
in T cell stimulation assays. The murine class II MHC proteins consti- Fritz, R.B., and McFarlin, D.E. (1989). Encephalitogenic epitopes of
tuting I-Au were isolated as described (Mason et al., 1995). myelin basic protein. Chem. Immunol. 46, 101±125.
In brief, cells expressing I-Au were detergent-lysed, and the lysate Fritz, R.B., and Zhao, M.L. (1996). Thymic expression of myelin basic
was passed over a lentil lectin column that was subsequently eluted protein (MBP). Activation of MBP-specific T cells by thymic cells in
with methyl mannoside onto an affinity column (10.3.6 anti-I-Au anti- the absence of exogenous MBP. J. Immunol. 157, 5249±5253.
body). The affinity column was eluted at high pH and protein was
Fritz, R.B., Chou,C.H., andMcFarlin, D.E. (1983). Induction of experi-characterized by SDS polyacrylamide gel electrophoresis after dial-
mental allergic encephalomyelitis in PL/J and (SJL/J 3 PL/J)F1 miceysis. Solutions of peptide and protein in 2 mM dodecyl maltoside
by myelin basic protein and its peptides: localization of a secondin PBS (pH 5.3) were incubated at 378C. Protein/peptide complexes
encephalitogenic determinant. J. Immunol. 130, 191±194.were isolated from excess peptide at 48C by size exclusion (Sepha-
Fritz, R.B., Skeen, M.J., Chou, C.H., Garcia, M., and Egorov, I.K.dex G50-SF) using 0.2 mM dodecyl maltoside in PBS (pH 7.4). The
(1985). Major histocompatibility complex-linked control of the mu-amount of fluorescein-labeled peptide bound to the protein was
rine immune response to myelin basic protein. J. Immunol. 134,measured as the amount of fluorescence associated with protein
2328±2332.separated by HPSEC using a TSK3000SW column (60 cm 3 7.5
Gammon, G., and Sercarz, E. (1989). How some T cells escapemm, Toso Haas, Montgomeryville, PA) with a fluorescence detector.
tolerance induction. Nature 342, 183±185.Competition reactions between labeled and unlabeled peptides
were used to confirm that the labels did not affect binding. For Garcia, K.C., Degano, M., Pease, L.R., Huang, M.D., Peterson, P.A.,
dissociation reactions, the complexes were formed in the presence Teyton, L., and Wilson, I.A. (1998). Structural basis of plasticity in T
cell receptor recognition of a self peptide MHC antigen. Scienceof excess peptide at 378C, isolated at 48C, and subsequently incu-
279, 1166±1172.bated at 378C. The amount of peptide bound to the complex was
determined at different times following the final incubation at 378C. Greer, J.M., Sobel, R.A., Sette, A., Southwood, S., Lees, M.B., and
Addition of excess unlabeled peptide did not affect the observed Kuchroo, V.K. (1996). Immunogenic and encephalitogenic epitope
dissociation kinetics. clusters of myelin proteolipid protein. J. Immunol. 156, 371±379.
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